Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

ARTL Artelo Biosciences Inc

1,34

-0,05 (-3,60%)

Après les heures de négociation

Dernière mise à jour : 22:10:52

Retardé de 15 minutes

Form EFFECT - Notice of Effectiveness

Artelo Biosciences (NASDAQ:ARTL)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024

Plus de graphiques de la Bourse Artelo Biosciences

Artelo Biosciences (NASDAQ:ARTL)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024

Plus de graphiques de la Bourse Artelo Biosciences

Actualités Artelo Biosciences Inc

Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th
Vendredi 10 Mai 2024 ( il y a 8 heures) • GlobeNewswire Inc.

Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy
Mardi 23 Avril 2024 ( il y a 2 semaines) • GlobeNewswire Inc.

Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time
Lundi 22 Avril 2024 ( il y a 3 semaines) • GlobeNewswire Inc.

Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
Lundi 25 Mars 2024 ( il y a 2 mois) • GlobeNewswire Inc.

Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge
Mardi 12 Mars 2024 ( il y a 2 mois) • GlobeNewswire Inc.

Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy
Mardi 23 Janvier 2024 ( il y a 4 mois) • GlobeNewswire Inc.

Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12
Lundi 8 Janvier 2024 ( il y a 4 mois) • GlobeNewswire Inc.

Artelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany
Mardi 5 Décembre 2023 ( il y a 5 mois) • GlobeNewswire Inc.

Artelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany
Jeudi 30 Novembre 2023 ( il y a 5 mois) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Lundi 13 Novembre 2023 ( il y a 6 mois) • Edgar (US Regulatory)

Artelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update
Lundi 13 Novembre 2023 ( il y a 6 mois) • GlobeNewswire Inc.

Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain Cancers
Jeudi 9 Novembre 2023 ( il y a 6 mois) • GlobeNewswire Inc.

Plus d'articles sur Artelo Biosciences Inc

Societe Generale

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales